Non-Small Cell Lung Cancer Market Size is Projected to Exhibit USD 36.9 billion by 2031 | F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Astrazeneca

Non-small cell lung cancer is a type of lung cancer, in which malignant tumor cells are formed in the lungs. It includes group of different diseases, which behave similarly such as squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Adenocarcinoma is a type of non-small cell lung cancer, which is more common in women than men and more in young people than old age group of people. It is found common in people who have a history of smoking and those who are exposed to polluted air more than those who smoke regularly. Squamous cell carcinoma is another common type of non-small cell lung cancer, which mostly occurs due to smoking tobacco. It mostly occurs in the central part of the lungs, which is near to the main airway. Large cell carcinoma can be harder to treat as it can be found in any part of the lung and tends to spread faster than the rest of the two.

Allied Market Research has just completed and published a study report with the title Non-Small Cell Lung Cancer Market Size was Valued at USD 15.3 billion in 2021, and is Projected to Garner USD 36.9 billion by 2031, registering a CAGR of 9.3% from 2022 to 2031.

𝐏𝐫𝐢𝐦𝐞 𝐝𝐞𝐭𝐞𝐫𝐦𝐢𝐧𝐚𝐧𝐭𝐬 𝐨𝐟 𝐠𝐫𝐨𝐰𝐭𝐡

Rise in prevalence of lung cancer occur in people who smoke and consume tobacco drive the growth of the global non small cell lung cancer market. However, high-cost expenditure in the treatment of non-small cell lung cancer and stringent government rules for product approval restrict the market growth. Moreover, widespread use of sneakers in numerous environments and a large consumer base including fitness & gym visitors, athletes, and rock climbers, present new opportunities in the coming years.

Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/666

The top Companies In Non-Small Cell Lung Cancer Market are 𝐅. 𝐇𝐨𝐟𝐟𝐦𝐚𝐧𝐧-𝐋𝐚 𝐑𝐨𝐜𝐡𝐞 𝐋𝐭𝐝, 𝐍𝐨𝐯𝐚𝐫𝐭𝐢𝐬 𝐀𝐆, 𝐏𝐟𝐢𝐳𝐞𝐫 𝐈𝐧𝐜., 𝐀𝐬𝐭𝐫𝐚𝐳𝐞𝐧𝐞𝐜𝐚, 𝐄𝐥𝐢 𝐋𝐢𝐥𝐥𝐲 𝐚𝐧𝐝 𝐂𝐨𝐦𝐩𝐚𝐧𝐲, 𝐌𝐞𝐫𝐜𝐤 & 𝐂𝐨., 𝐈𝐧𝐜., 𝐁𝐫𝐢𝐬𝐭𝐨𝐥-𝐌𝐲𝐞𝐫𝐬 𝐒𝐪𝐮𝐢𝐛𝐛 𝐂𝐨𝐦𝐩𝐚𝐧𝐲, 𝐂𝐞𝐥𝐠𝐞𝐧𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧, 𝐒𝐚𝐧𝐨𝐟𝐢, 𝐛𝐨𝐞𝐡𝐫𝐢𝐧𝐠𝐞𝐫 𝐢𝐧𝐠𝐞𝐥𝐡𝐞𝐢𝐦

𝐍𝐨𝐧-𝐒𝐦𝐚𝐥𝐥 𝐂𝐞𝐥𝐥 𝐋𝐮𝐧𝐠 𝐂𝐚𝐧𝐜𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: -

Based on type, the adenocarcinoma segment held the highest market share in 2021, accounting for nearly half of the global non small cell lung cancer market, and is estimated to maintain its leadership status throughout the forecast period, owing to rise in smoking on regular basis around the globe.

Based on treatment type, the targeted therapy segment held the highest market share in 2021, accounting for more than half of the global non small cell lung cancer market, and is estimated to maintain its leadership status throughout the forecast period, owing to its potential to prevent the growth of malignant cells.

Based on distribution channel, the hospital pharmacy segment accounted for the largest share in 2021, contributing to more than two-thirds of the global non small cell lung cancer market, and is projected to maintain its lead position during the forecast period. This is owing to prevalence of non-small cell lung cancer diseases, such as adenocarcinoma and large cell carcinoma and increase in number of hospitalization of patients suffering with NSCLC.

Based on region, North America held the highest market share in terms of revenue in 2021, accounting for around two-fifths of the global non small cell lung cancer market, and is likely to dominate the market during the forecast period, owing to the presence of key players, rising government initiatives, well-developed healthcare infrastructure, and rising awareness about the innovations in healthcare sector. However, the Asia-Pacific region is expected to witness the fastest CAGR of 10.5% from 2022 to 2031, owing to the investments by the public and private market players in this field.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/666

Our Market Research Solution Provides You Answer to Below Mentioned Question:

Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
How will each segment grow over the forecast period and how much revenue will these segments account for in 2028?
Which region has more opportunities?

By Region Outlook

North America

⦁ U.S.

⦁ Canada

⦁ Mexico

Europe

⦁ UK

⦁ Germany

⦁ France

⦁ Italy

⦁ Russia

⦁ Rest of Europe

Asia-Pacific

⦁ China

⦁ Japan

⦁ India

⦁ Australia

⦁ Rest of Asia-Pacific

LAMEA

⦁ Brazil

⦁ UAE

⦁ Turkey

⦁ Saudi Arabia

⦁ Rest of LAMEA

Get Full Report: https://www.alliedmarketresearch.com/non-small-cell-lung-cancer-market

Top Trending Reports:

Digital Pathology Market: https://www.openpr.com/news/2895647/rising-demand-of-digital-pathology-market-size-is-poised

Albumin Market: https://www.openpr.com/news/2895991/rising-demand-of-albumin-market-size-is-poised-to-expand-at-a-cagr

Smart Insulin Pens Market: https://www.openpr.com/news/2896678/here-s-how-smart-insulin-pens-market-can-benefit-the-healthcare

Left Atrial Appendage (LAA) Closure Device Market: https://www.openpr.com/news/2896887/left-atrial-appendage-closure-device-market-2023-segmentation

Medical Tourism Market: https://www.openpr.com/news/2884179/medical-tourism-market-size-worth-usd-273-72-billion-by-2027

3D Cell Culture Market: https://www.openpr.com/news/2884240/3d-cell-culture-market-share-growing-rapidly-with-recent-trends

Molecular Diagnostics Market: https://www.openpr.com/news/2884363/molecular-diagnostics-market-can-revolutionize-healthcare

Electrolarynx Market: https://www.openpr.com/news/2899270/electrolarynx-market-size-to-witness-widespread-expansion

Endoscopic Spinal Surgery Market: https://www.openpr.com/news/2899452/endoscopic-spinal-surgery-market-global-investor-latest

Antinuclear Antibody Test Market: https://www.openpr.com/news/2900418/rising-demand-for-antinuclear-antibody-test-market-size

Orthopedic Implants Market: https://www.openpr.com/news/2900423/orthopedic-implants-market-size-is-slated-to-witness-tremendous

David Correa

5933 NE Win Sivers Drive

205, Portland, OR 97220

United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.